HUTCHMED (China) Limited
HCM
$14.20
-$0.10-0.70%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 135.42M | 135.42M | 138.84M | 138.84M | 162.26M |
| Total Other Revenue | -- | -- | -- | -- | -68.52M |
| Total Revenue | 135.42M | 135.42M | 138.84M | 138.84M | 162.26M |
| Cost of Revenue | 158.53M | 158.53M | 83.79M | 83.79M | 190.43M |
| Gross Profit | -23.12M | -23.12M | 55.05M | 55.05M | -28.17M |
| SG&A Expenses | 30.70M | 30.70M | 20.81M | 20.81M | 27.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 153.24M | 153.24M | 140.60M | 140.60M | 170.35M |
| Operating Income | -17.82M | -17.82M | -1.76M | -1.76M | -8.09M |
| Income Before Tax | 1.31M | 1.31M | 259.36M | 259.36M | 8.16M |
| Income Tax Expenses | 224.00K | 224.00K | 31.58M | 31.58M | 2.15M |
| Earnings from Continuing Operations | 1.09M | 1.09M | 227.78M | 227.78M | 6.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -111.00K | -111.00K | -300.50K | -300.50K | -38.50K |
| Net Income | 977.50K | 977.50K | 227.48M | 227.48M | 5.96M |
| EBIT | -17.82M | -17.82M | -1.76M | -1.76M | -8.09M |
| EBITDA | -14.23M | -14.23M | 1.30M | 1.30M | -5.05M |
| EPS Basic | 0.00 | 0.00 | 0.27 | 0.27 | 0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
| EPS Diluted | 0.00 | 0.00 | 0.26 | 0.26 | 0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
| Average Basic Shares Outstanding | 859.51M | 859.51M | 857.04M | 857.04M | 854.67M |
| Average Diluted Shares Outstanding | 873.22M | 873.22M | 872.56M | 872.56M | 873.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |